UBS O'Connor’s DTRT Health Acquisition Corp. Class A Common Stock DTRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-243,293
Closed -$2.47M 739
2022
Q3
$2.47M Sell
243,293
-24,356
-9% -$246K 0.03% 501
2022
Q2
$2.69M Buy
+267,649
New +$2.69M 0.03% 491
2022
Q1
Sell
-262,932
Closed -$2.64M 597
2021
Q4
$2.64M Buy
+262,932
New +$2.62M 0.03% 429

Other funds holding DTRT

UBS O'Connor's DTRT Position: Q4 2022 in Review

UBS O'Connor sold out of DTRT Health Acquisition Corp. Class A Common Stock (DTRT) in Q4 2022, closing a stake of 243,293 shares — an estimated $2.47M sold.

UBS O'Connor first reported a position in DTRT in Q4 2021 and held it in 3 quarters. The position peaked at $2.69M in Q2 2022. 17 funds tracked by Wall St. Rank hold DTRT as of Q4 2022.

  • UBS O'Connor reported no remaining DTRT Health Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 243,293 DTRT Health Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $2.47M.
  • UBS O'Connor first reported a position in DTRT Health Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 3 quarters.
  • UBS O'Connor's DTRT Health Acquisition Corp. Class A Common Stock position peaked at $2.69M in Q2 2022.
  • 17 funds tracked by Wall St. Rank held DTRT Health Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.